Objective

2

To evaluate the clinical efficacy of ultrasound-guided needle knife release with different pathways for carpal tunnel syndrome (CTS).

Methods

2

Sixty CTS patients were randomly divided into a transverse group and a longitudinal group

with 30 patients in each group. The transverse group received the needle knife release under ultrasound above and below the median nerve along the short axis

while the longitudinal group received the needle knife release under ultrasound above the median nerve along the long axis. The patients' visual analogue scale (VAS) scores

Levine scores

and median nerve cross-section area (CSA) were assessed before treatment

on the 7th

14th

and 30th days after treatment. The median nerve conduction indexes (motor conduction: latency [Lat]

amplitude[Amp]

motor conduction velocity [MCV]; sensory conduction: Lat

Amp

sensory conduction velocity [SCV]) were evaluated before treatment and on the 30th day after treatment.

Results

2

Compared before treatment

the VAS scores

Levine scores

and median nerve CSA were reduced in both groups on the 7th

14th

and 30th days after treatment (

P

<

0.05); the transverse group showed lower VAS and Levine scores and smaller CSA than those in the longitudinal group (

P

<

0.05). On the 30th day after treatment

motor and sensory Lat was reduced (

P

<

0.05)

motor and sensory Amp was increased (

P

<

0.05)

and MCV and SCV were faster (

P

<

0.05) in both groups. The transverse group had shorter Lat

higher Amp

and faster MCV and SCV than those in the longitudinal group (

P

<

0.05).

Conclusion

2

The ultrasound-guided needle knife release with transverse and longitudinal pathways could both effectively alleviate pain and improve median nerve conduction in CTS patients

with the transverse pathway showing superior efficacy to longitudinal pathway.